Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 12;51(1):14.
doi: 10.1007/s11033-023-08931-2.

The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers

Affiliations
Review

The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers

Shen Lin et al. Mol Biol Rep. .

Abstract

Typically associated with solid tumors, hypoxia contributes to tumor angiogenesis and lymphangiogenesis through various molecular mechanisms. Accumulating studies indicate that hypoxia-inducible factor is the key transcription factor coordinating endothelial cells to respond to hypoxia in urological cancers, mainly renal cell carcinoma, prostate cancer, and bladder cancer. Moreover, it has been suggested that tumor hypoxia in tumor microenvironment simultaneously recruits stromal cells to suppress immune activities. This review summarizes the mechanisms by which HIF regulates tumorigenesis and elaborates on the associations between HIF and angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers.

Keywords: Angiogenesis; HIF; Lymphangiogenesis; Tumor microenvironment; Urological cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Regulation of tumor-associated lymphangiogenesis by HIF-1α
Fig. 2
Fig. 2
Schematic overview of HIF-induced angiogenesis, lymphangiogenesis and immune suppression

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Schito L, Semenza GL. Hypoxia-inducible factors: Master regulators of Cancer Progression. Trends in Cancer. 2016;2:758–770. doi: 10.1016/j.trecan.2016.10.016. - DOI - PubMed
    1. Semenza GL. Oxygen sensing, Hypoxia-Inducible factors, and Disease Pathophysiology. Annu Rev Pathol Mech Dis. 2014;9:47–71. doi: 10.1146/annurev-pathol-012513-104720. - DOI - PubMed
    1. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–5514. doi: 10.1073/pnas.92.12.5510. - DOI - PMC - PubMed
    1. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG., Jr HIFα targeted for VHL-Mediated Destruction by Proline Hydroxylation: implications for O 2 sensing. Science. 2001;292:464–468. doi: 10.1126/science.1059817. - DOI - PubMed

Substances